Heartsciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Heartsciences Inc in the first quarter 2026?
Heartsciences Inc recorded a cumulative net loss of $-10 million during 12 months ending in the first quarter 2026, resulting in a negative return on equity (ROE) of -847.91%.

Within the Medical Equipment & Supplies industry 190 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2026 from 4364 to 4536.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jul 31 2026) I. Quarter	(Apr 30 2026) IV. Quarter	(Jan 31 2026) III. Quarter	(Oct 31 2025) II. Quarter	(Jul 31 2025) I. Quarter
Y / Y Equity Change	-92.8 %	10.18 %	-97.2 %	4.13 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-10	-9	-8	-9	-9
Return On Equity (TTM)	-847.91 %	-471.55 %	-438.86 %	-243.47 %	-238.92 %
HSCS's Total Ranking	# 4536	# 4364	# 2930	# 3515	# 3515
Equity (TTM) in Millions	0	0	0	4	3
Seq. Equity Change	0 %	10.18 %	-95.09 %	33.15 %	1430.97 %
Seq. Net Income Change	-	-	-	-	-

Back to HSCS Management Effectiveness >> HSCS's 5 Years Annual ROE >> Compare HSCS ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 191
Sector	# 840
Overall	# 4536

Return On Equity Statistics
High	Average	Low
-138.57 %	-727.32 %	-4591.21 %
(Jan 31 2025)		(Jul 31 2023)

HSCS Annual Return On Equity	(Apr 30 2026) 2026	(Apr 30 2025) 2025	(Apr 30 2024) 2024	(Apr 30 2023) 2023
Total Equity in Millions	0	0	7	0	0
Y / Y Equity Change	10.18 %	-97.2 %	3073.75 %	-	-
Net Income in Millions	-9	-9	-7	-6	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-4044 %	-4272.16 %	-90.27 %	-2756.06 %	-

Back to HSCS Management Effectiveness >> HSCS's 5 Years Annual ROE >> Compare HSCS ROE to its Competitors

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HSCS's' Return on Equity at Yahoo Finance
HSCS's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HSCS's Competitors
Subscribers only: Roe for Heartsciences Inc 's Suppliers
Subscribers only: Return On Equity for HSCS's Customers

Companies with similar Return On Equity at Jul 31 2026, within Healthcare Sector

ROE

Date modified: 2026-09-15T11:54:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.